The IP "collection" doesn't have any value. The psoriasis patent has very little value since it doesn't have FDA approval and OWCP hasn't started FDA approved clinical trials - in 2017 OWCP stated they were going to apply for Orphan Drug Status on the MM drug and that still hasn't been done.
"The collection of in process patents are quite valuable. Some near issusance and others ready for a successor to fine tune to incorporate their proprietary IP. The condom patent is years onto the process as is the MM patent."
There are already CBD infused condoms on the market - so when submitting prior art there isn't any innovation.